<DOC>
	<DOCNO>NCT02098239</DOCNO>
	<brief_summary>The study design assess effect jaundice ability G17DT generate antibody treatment biliary obstruction due advance pancreatic cancer .</brief_summary>
	<brief_title>Single Centre Study Determine Antibody Response G17DT Patients With Advanced Pancreatic Cancer .</brief_title>
	<detailed_description>Jaundiced patient advanced pancreatic cancer ( either locally , advance metastatic ) treat G17DT either immediately ( Group A ) , follow biliary stenting jaundice resolve ( Group B ) . Patients jaundiced time presentation enter Group B . Patients receive 3 Intramuscular injection G17DT week 0 , 1 , 3 . A booster injection offer patient measurable anit-G17Dt antibody anti-G17DT antibody fell pre-specified threshold week 23 . Patients evaluate study closure ort patient death .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Jaundice</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Gastrins</mesh_term>
	<criteria>Patients pancreatic adenocarcinoma ( cytologically histologically prove ) , suitable potentially curative resection . If patient jaundice , bilirubin &gt; 80 μmol/L . Male female patient 18 year age . World Health Organization ( WHO ) performance status 0 2 . Patients life expectancy least 8 week . Patients must give write informed consent . Patients undergo potentially curative resection . Jaundiced patient bilirubin value &lt; 80 μmol/L . Patients consider fit endoscopic percutaneous biliary stenting . Patients receive anticancer therapy . History malignant disease except nonmelanomatous skin cancer situ carcinoma cervix . Females pregnant , plan become pregnant , lactate . Patients take part another study involve investigational license drug device three month precede enrolment study . Previous G17DT treatment . Haematological indicator : Haemoglobin ( Hb ) &lt; 10.0 g/dL . White cell count ( WCC ) &lt; 4.0×109/L . Platelets &lt; 100×109/L .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>